Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Sep 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 11.74 | 33,920 | 398.22 k | 33,920 |
1 Mar 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.13 | 965,435 | 1.09 mm | 965,435 |
28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 57,749 | 55.44 k | 57,749 |
28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 230,999 | 221.76 k | 230,999 |
28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 132,352 | 127.06 k | 132,352 |
27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.06 | 80,850 | 247.40 k | 0 |
27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.06 | 323,400 | 989.60 k | 0 |
27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 16.18 | 450,000 | 7.28 mm | 0 |
25 Oct 23 | ALGS Aligos Therapeutics | Common Stock | Grant | Acquire A | No | No | 0.7568 | 610,277 | 461.86 k | 1,847,575 |
25 Oct 23 | ALGS Aligos Therapeutics | Warrants Common Stock | Grant | Acquire A | No | No | 0.125 | 305,138 | 38.14 k | 305,138 |